Canaccord Genuity Reiterates Buy Rating on Exagen (XGN) Jan 12, 2026 06:42AM
Canaccord Genuity Reiterates Buy Rating on Exagen (XGN) Nov 18, 2025 06:18AM
Exagen Inc. to Participate in Fourth Quarter Investor Conferences Nov 11, 2025 09:00AM
Exagen Inc. to Participate in Third Quarter Investor Conferences Aug 6, 2025 04:05PM
Exagen Inc. Announces Closing of $20.2 Million Public Offering Including Full Exercise of Underwriter’s Option to Purchase Additional Shares May 9, 2025 04:05PM


May 8, 2025 08:31AM Exagen Inc (XGN) Prices 3.5M Share Offering at $5.25/sh
May 8, 2025 08:30AM Exagen Inc. Prices Public Offering of Common Stock
May 7, 2025 04:05PM Exagen Inc (XGN) Announces Proposed Public Offering of Common Stock
May 7, 2025 04:05PM Exagen Inc. Announces Proposed Public Offering of Common Stock
Nov 13, 2024 04:05PM Exagen Inc. to Participate in Fourth Quarter Investor Conferences
Aug 2, 2024 09:00AM Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference
May 14, 2024 08:00AM Canaccord Genuity Reiterates Buy Rating on Exagen (XGN)
Nov 2, 2023 04:05PM Exagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Nov 2, 2023 04:05PM Exagen Inc. to Participate in the 2023 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
Jul 26, 2023 04:05PM Exagen Inc. to Participate in the Canaccord Genuity 43rd Annual Growth Conference
Nov 8, 2022 04:05PM Exagen Inc. to Participate in Fourth Quarter Investor Conferences
Nov 8, 2022 04:05PM Exagen Inc. to Participate in Fourth Quarter Investor Conferences
Jul 25, 2022 04:05PM Exagen Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference
Jul 25, 2022 04:05PM Exagen Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference
Nov 4, 2021 04:05PM Exagen Inc. to Participate in the 2021 Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health and Services Forum
Nov 4, 2021 04:05PM Exagen Inc. to Participate in the 2021 Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health and Services Forum
Jul 29, 2021 08:25AM Exagen Inc. to Participate in the Canaccord Genuity 41st Annual Growth Conference
Jul 29, 2021 08:25AM Exagen Inc. to Participate in the Canaccord Genuity 41st Annual Growth Conference
Mar 25, 2021 04:15PM Exagen Inc. Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Mar 25, 2021 04:15PM Exagen Inc. Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Mar 23, 2021 05:59AM Exagen Inc (XGN) Prices 3.7M Share Common Offering at $16.25/Sh
Mar 22, 2021 10:01PM Exagen Inc. Announces Pricing of Public Offering of Common Stock
Mar 22, 2021 10:01PM Exagen Inc. Announces Pricing of Public Offering of Common Stock
Mar 22, 2021 04:06PM Exagen Inc (XGN) Announces Proposed Public Offering of Common Stock
Mar 22, 2021 04:05PM Exagen Inc. Announces Proposed Public Offering of Common Stock
Mar 22, 2021 04:05PM Exagen Inc. Announces Proposed Public Offering of Common Stock
Nov 9, 2020 08:25AM Exagen Inc. To Participate in November Investor Conferences
Nov 9, 2020 08:25AM Exagen Inc. To Participate in November Investor Conferences
Jul 30, 2020 04:25PM Exagen to Present at the Canaccord Genuity 40th Annual Growth Conference
Jul 30, 2020 04:25PM Exagen to Present at the Canaccord Genuity 40th Annual Growth Conference
Nov 7, 2019 08:14AM Exagen to Participate in Canaccord Genuity 13th Annual MedTech & Diagnostics Forum on November 21, 2019
Nov 7, 2019 08:14AM Exagen to Participate in Canaccord Genuity 13th Annual MedTech & Diagnostics Forum on November 21, 2019